Ken Griffin's position in Sage Therapeutics is currently worth $5.88 Million. That's 0.01% of their equity portfolio (1412th largest holding). The first Sage Therapeutics trade was made in Q3 2014. Since then Ken Griffin bought shares 55 more times and sold shares on 39 occasions. The investor's estimated purchase price is $24.8 Million, resulting in a loss of 76%.